- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 25.04. | BioMarin drops drug programs in pipeline cull | ||
| 25.04. | Bristol Myers to cut 6% of workforce, trim drug pipeline | ||
| 25.04. | Regeneron expands in gene editing with Mammoth deal | ||
| 24.04. | Biogen: Don't expect any big acquisitions this year | ||
| 24.04. | Moderna turns to AI to change how its employees work | ||
| 24.04. | Biogen sees 'encouraging' trends for postpartum depression drug | ||
| 24.04. | Biogen to invest more in launch of Alzheimer's drug Leqembi | ||
| 24.04. | [Podcast] Partner for Progress: Strategies for Biotech Success | ||
| 24.04. | CureVac to cut costs in restructuring | ||
| 24.04. | Endeavor pulls in $132M to back cancer, lung disease drugs | ||
| 23.04. | Former Bristol Myers CEO tapped as Novartis' next board chair | ||
| 23.04. | Novartis raises forecasts as top drug sales beat Wall Street estimates | ||
| 23.04. | Neurocrine scores surprise win with depression drug | ||
| 23.04. | FDA rejects Abeona cell therapy, asks for more manufacturing data | ||
| 23.04. | Lilly to buy injectable drug plant in manufacturing ramp-up | ||
| 22.04. | Ipsen, Skyhawk to develop RNA-targeting pills for rare brain diseases | ||
| 22.04. | Eisai hunts for next Alzheimer's drug with new research pact | ||
| 22.04. | Bristol Myers taps startup to boost cell therapy production | ||
| 22.04. | Pharmas form joint venture to jumpstart Japanese drug research | ||
| 22.04. | How can pharma speed time to treatment? Digital tools can help | ||
| 19.04. | Alvotech deal could heighten biosimilar pressure on Humira | ||
| 19.04. | Roche wins FDA OK for targeted drug in early lung cancer | ||
| 18.04. | 23andMe CEO plans to take company private | ||
| 18.04. | Vertex begins bid for US approval of non-opioid painkiller | ||
| 18.04. | Cerevel, in 'major surprise,' finds success in late-stage Parkinson's study |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
